Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 73715734 | 7371573 | 4 | F | 20130916 | 20100430 | 20130930 | EXP | US-RANBAXY-2010US-33354 | RANBAXY | 67.00 | YR | F | Y | 64.50000 | KG | 20130930 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 73715734 | 7371573 | 1 | PS | Ramipril | 1 | ORAL | 5 MG/DAY | D | 78849 | ||||||||||
| 73715734 | 7371573 | 2 | C | Adalimumab | 1 | UNKNOWN | UNK | D | 0 | ||||||||||
| 73715734 | 7371573 | 3 | C | Adalimumab | 1 | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 73715734 | 7371573 | 1 | Hypertension |
| 73715734 | 7371573 | 2 | Rheumatoid arthritis |
| 73715734 | 7371573 | 3 | Psoriatic arthropathy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 73715734 | 7371573 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 73715734 | 7371573 | Pustular psoriasis | |
| 73715734 | 7371573 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |